189 related articles for article (PubMed ID: 3718401)
1. Increased risk of thrombosis due to abnormalities of the hemostatic system.
Lechner K; Pabinger-Fasching I; Korninger C; Niessner H
Behring Inst Mitt; 1986 Feb; (79):1-8. PubMed ID: 3718401
[TBL] [Abstract][Full Text] [Related]
2. Blood viscosity and thrombosis: clinical considerations.
Smith BD; La Celle PL
Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
[TBL] [Abstract][Full Text] [Related]
3. [Thyroid and hemostasis].
Franchini M
Recenti Prog Med; 2006 May; 97(5):267-71. PubMed ID: 16838559
[TBL] [Abstract][Full Text] [Related]
4. Assessment of hemostatic risk factors in predicting arterial thrombotic events.
Feinbloom D; Bauer KA
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2043-53. PubMed ID: 16100033
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic and hemorrhagic problems in neurosurgical patients.
Gerlach R; Krause M; Seifert V; Goerlinger K
Acta Neurochir (Wien); 2009 Aug; 151(8):873-900; discussion 900. PubMed ID: 19557305
[TBL] [Abstract][Full Text] [Related]
6. [Hemostatic anomalies and coronary risk].
de Lorgeril M; Renaud S
Rev Prat; 1992 Nov; 42(17):2136-40. PubMed ID: 1290035
[TBL] [Abstract][Full Text] [Related]
7. Risk associations in the thrombotic disorders.
Meade TW
Clin Haematol; 1981 Jun; 10(2):391-405. PubMed ID: 7032782
[No Abstract] [Full Text] [Related]
8. Hypercoagulable states as an evolving risk for spontaneous venous and arterial thrombosis.
Levy PJ; Gonzalez FM; Rush DS; Haynes JL
J Am Coll Surg; 1994 Mar; 178(3):266-70. PubMed ID: 8149019
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
10. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states.
Feied CF
Semin Dermatol; 1993 Jun; 12(2):135-49. PubMed ID: 8512794
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis and bleeding: when opposites are not so far apart.
Franchini M; Veneri D
Clin Lab; 2005; 51(3-4):173-82. PubMed ID: 15819173
[TBL] [Abstract][Full Text] [Related]
12. [The skin manifestations of congenital and acquired hemostatic disorders].
Zerbino DD; Dubovoĭ MI; Zaĭchenko AI; Lukasevich LL; Bilinskaia OA
Vestn Dermatol Venerol; 1990; (4):62-7. PubMed ID: 2202169
[TBL] [Abstract][Full Text] [Related]
13. [Venous thromboembolic pathology. New acquired risk factors or new data on acquired risk factors].
Drouet L
Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1318-26. PubMed ID: 11794976
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic abnormalities and liver diseases.
Wada H; Usui M; Sakuragawa N
Semin Thromb Hemost; 2008 Nov; 34(8):772-8. PubMed ID: 19214915
[TBL] [Abstract][Full Text] [Related]
15. Interactions between genotype and phenotype in bleeding and thrombosis.
Franchini M; Mannucci PM
Haematologica; 2008 May; 93(5):649-52. PubMed ID: 18450734
[TBL] [Abstract][Full Text] [Related]
16. The investigation of a heart valve patient with suspected hypercoagulability.
Gough SC; Prentice CR
J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
[TBL] [Abstract][Full Text] [Related]
17. [Disorders of the hemostatic system in patients with disseminated stomach cancer].
Tiutrin II; Karpov AB; Udut VV; Tsisik RM; Solokhina EA
Vopr Onkol; 1989; 35(4):460-5. PubMed ID: 2728389
[TBL] [Abstract][Full Text] [Related]
18. [Blood coagulation changes and neoplastic pathology].
Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D
Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
